About Biolife Group
BioLife Group is a pioneering force in plant-based medicine, bridging the gap between advanced research and sustainable cultivation. From our farms in Byron Bay and Thailand, we cultivate high-quality, organic cannabis, driven by a mission to improve patient access to effective therapies.
Cultivating Healing, Nurturing Wellness.
Cultivating Healing, Nurturing Wellness
At BioLife Group, we’re more than just cultivators of plant-based medicine; we’re pioneers dedicated to bridging the gap between nature and science to improve patient lives.
Founded in 2017 with a vision to revolutionize access to high-quality, natural therapies, we’ve grown from our roots as a pioneering force in the Australian hemp industry to become a leading global player in the cultivation and research of organic cannabis. Our journey is driven by a deep respect for the healing power of nature, combined with a relentless pursuit of scientific innovation and a steadfast commitment to sustainability.
CEO
Our "Farm-to-Patient" philosophy is the cornerstone of our operations. We believe that true quality and efficacy begin at the source. By meticulously controlling every stage of the process, from seed selection and cultivation to processing and distribution, we ensure the highest standards of quality, purity, and consistency in every product we offer.
+61 423 423 452
Contact Us
99.9% Customer Satisfaction based on 750+ reviews of 6,154 Completed Projects, and 2,194 Happy Customers trust us.
Based on 12-Month performance across key operations.
- Projects in Australia
- Clinics
- Projects in Germany
- Projects in Thailand
In July 2024, BLG acquired a 20% equity stake in Alliance Healthcare Australia (AHA), making Alliance Healthcare a fully vertically integrated pharmaceutical company.
In October 2024 BLG acquired 90% of Oriental Plantation in Korat, strengthening our position as one of the largest medical cannabis producers in Thailand.
Market Value
With a vision to help create a world where plant based medicine is accessible to patients.
BLG Growth In 2024
Achieving the Farm-to-Patient Strategic Objective through the development and delivery of THC and CBD products by the midpoint of FY26.
Years Of Experience
Experts in Pharmacy, Management and Product Development.